Tid1 functions as a tumour suppressor in head and neck squamous cell carcinoma

Journal of Pathology

Volumn 219, Issue 3, 2009, Pages 347-355

  Chen, Chi Yuan ^a   Chiou, Shih Hwa ^a,b   Huang, Chih Yang ^c,d   Jan, Chia Ing ^c   Lin, Shu Chun ^a   Hu, Wen Yuan ^e   Chou, Shiu Huey ^f   Liu, Chung Ji ^g   Lo, Jeng Fan ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e Biosettia Inc   (United States)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^g MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

AKT; EGFR; Head and neck cancer; Tid1; Tumour suppressor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN KINASE B; PROTEIN TID 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANCHORAGE INDEPENDENT GROWTH; APOPTOSIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; XENOTRANSPLANTATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; AGED; ANIMALS; APOPTOSIS; CARCINOMA, SQUAMOUS CELL; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HEAD AND NECK NEOPLASMS; HSP40 HEAT-SHOCK PROTEINS; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 70350449109     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2604     Document Type: Article

References (38)

1. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nature Rev Cancer 2005;5:127-135. (Pubitemid 40220338)
2. Chen YJ, Chang JT, Liao CT, Wang HM, Yen TC, Chiu CC, et al. Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci 2008;99:1507-1514.
3. Chen YJ, Lin SC, Kao T, Chang CS, Hong PS, Shieh TM, et al. Genome-wide profiling of oral squamous cell carcinoma. J Pathol 2004;204:326-332. (Pubitemid 39430093)
4. Molinolo AA, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 2009;45:324-334.
5. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nature Rev Mol Cell Biol 2001;2:127-137.
6. Vairaktaris E, Spyridonidou S, Papakosta V, Vylliotis A, Lazaris A, Perrea D, et al. The hamster model of sequential oral oncogenesis. Oral Oncol 2008;44:315-324.
7. Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Rev Cancer 2005;5:341-354. (Pubitemid 40637826)
8. Ang KK, Berkey BA, Tu X, Zhang HZ, Katz R, Hammond EH, et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002;62:7350-7356. (Pubitemid 36025259)
9. Hanahan D, Weinberg RA. The hallmarks of Cancer. Cell Stress Chaperones 2000;100:57-70.
10. Amornphimoltham P, Sriuranpong V, Patel V, Benavides F, Conti CJ, Sauk J, et al. Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01. Clin Cancer Res 2004;10:4029-4037. (Pubitemid 38812478)
11. Bussink J, van der Kogel AJ, Kaanders JH. Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer. Lancet Oncol 2008;9:288-296. (Pubitemid 351722948)
12. Grandis JR. Established and emerging concepts in epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 2007;69:S22-S24. (Pubitemid 47369383)
13. Pomerantz RG, Grandis JR. The epidermal growth factor receptor signaling network in head and neck carcinogenesis and implications for targeted therapy. Semin Oncol 2004;31:734-743.
14. Kurzik-Dumke U, Gundacker D, Renthrop M, Gateff E. Tumor suppression in Drosophila is causally related to the function of the lethal(2) tumorous imaginal discs gene, a dnaJ homolog. Dev Genet 1995;16:64-76.
15. Syken J, De-Medina T, Munger K. TID1, a human homolog of the Drosophila tumor suppressor l(2)tid, encodes two mitochondrial modulators of apoptosis with opposing functions. Proc Natl Acad Sci U S A 1999;96:8499-8504. (Pubitemid 29354820)
16. Schilling B, De-Medina T, Syken J, Vidal M, Munger K. A novel human DnaJ protein, hTid-1, a homolog of the Drosophila tumor suppressor protein Tid56, can interact with the human papillomavirus type 16 E7 oncoprotein. Virology 1998;247:74-85. (Pubitemid 28384027)
17. Lo JF, Hayashi M, Woo-Kim S, Tian B, Huang JF, Fearns C, et al. Tid1, a cochaperone of the heat shock 70 protein and the mammalian counterpart of the Drosophila tumor suppressor l(2)tid, is critical for early embryonic development and cell survival. Mol Cell Biol 2004;24:2226-2236. (Pubitemid 38325979)
18. Lo JF, Zhou H, Fearns C, Reisfeld RA, Yang Y, Lee JD. Tid1 is required for T cell transition from double-negative 3 to double-positive stages. J Immunol 2005;174:6105-6112. (Pubitemid 40663799)
19. Cheng H, Cenciarelli C, Shao Z, Vidal M, Parks WP, Pagano M, et al. Human T cell leukemia virus type 1 Tax associates with a molecular chaperone complex containing hTid-1 and Hsp70. Curr Biol 2001;11:1771-1775. (Pubitemid 33092165)
20. Kim SW, Hayashi M, Lo JF, Fearns C, Xiang R, Lazennec G, et al. Tid1 negatively regulates the migratory potential of cancer cells by inhibiting the production of interleukin-8. Cancer Res 2005;65:8784-8791. (Pubitemid 41377366)
21. Kim SW, Chao TH, Xiang R, Lo JF, Campbell MJ, Fearns C, et al. Tid1, the human homologue of a Drosophila tumor suppressor, reduces the malignant activity of ErbB-2 in carcinoma cells. Cancer Res 2004;64:7732-7739. (Pubitemid 39446904)
22. Canamasas I, Debes A, Natali PG, Kurzik-Dumke U. Understanding human cancer using Drosophila: Tid47, a cytosolic product of the DnaJ-like tumor suppressor gene l(2)Tid, is a novel molecular partner of patched related to skin cancer. J Biol Chem 2003;278:30952-30960. (Pubitemid 36994607)
23. Wakabayashi Y, Mao JH, Brown K, Girardi M, Balmain A. Promotion of Hras-induced squamous carcinomas by a polymorphic variant of the Patched gene in FVB mice. Nature 2007;445:761-765. (Pubitemid 46279707)
24. Kurzik-Dumke U, Horner M, Czaja J, Nicotra MR, Simiantonaki N, Koslowski M, et al. Progression of colorectal cancers correlates with overexpression and loss of polarization of expression of the htid-1 tumor suppressor. Int J Mol Med 2008;21:19-31. (Pubitemid 351222864)
25. Trentin GA, He Y, Wu DC, Tang D, Rozakis-Adcock M. Identification of a hTid-1 mutation which sensitizes gliomas to apoptosis. FEBS Lett 2004;578:323-330. (Pubitemid 39601801)
26. Shieh TM, Lin SC, Liu CJ, Chang SS, Ku TH, Chang KW. Association of expression aberrances and genetic polymorphisms of lysyl oxidase with areca-associated oral tumorigenesis. Clin Cancer Res 2007;13:4378-4385.
27. Lin SC, Liu CJ, Chiu CP, Chang SM, Lu SY, Chen YJ. Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract. J Oral Pathol Med 2004;33:79-86.
28. Laufen T, Mayer MP, Beisel C, Klostermeier D, Mogk A, Reinstein J, et al. Mechanism of regulation of hsp70 chaperones by DnaJ cochaperones. Proc Natl Acad Sci U S A 1999;96:5452-5457. (Pubitemid 29234638)
29. Kelley WL. Molecular chaperones: how J domains turn on Hsp70s. Curr Biol 1999;9:R305-R308.
30. Hung PS, Kao SY, Shih YH, Chiou SH, Liu CJ, Chang KW, et al. Insulin-like growth factor binding protein-5 (IGFBP-5) suppresses the tumourigenesis of head and neck squamous cell carcinoma. J Pathol 2008;214:368-376. (Pubitemid 351212392)
31. Chen IH, Chang JT, Liao CT, Wang HM, Hsieh LL, Cheng AJ. Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis. Br J Cancer 2003;89:681-686.
32. Dikic I, Giordano S. Negative receptor signalling. Curr Opin Cell Biol 2003;15:128-135.
33. Bae MK, Jeong JW, Kim SH, Kim SY, Kang HJ, Kim DM, et al. Tid-1 interacts with the von Hippel-Lindau protein and modulates angiogenesis by destabilization of HIF-1alpha. Cancer Res 2005;65:2520-2525.
34. Segrelles C, Moral M, Lara MF, Ruiz S, Santos M, Leis H, et al. Molecular determinants of Akt-induced keratinocyte transformation. Oncogene 2006;25:1174-1185. (Pubitemid 43297932)
35. Chun KH, Kosmeder JW 2nd, Sun S, Pezzuto JM, Lotan R, Hong WK, et al. Effects of deguelin on the phosphatidylinositol 3-kinase/Akt pathway and apoptosis in premalignant human bronchial epithelial cells. J Natl Cancer Inst 2003;95:291-302.
36. Lu B, Garrido N, Spelbrink JN, Suzuki CK. Tid1 isoforms are mitochondrial DnaJ-like chaperones with unique carboxyl termini that determine cytosolic fate. J Biol Chem2006;281:13150-13158.
37. Liu HY, MacDonald JI, Hryciw T, Li C, Meakin SO. Human tumorous imaginal disc 1 (TID1) associates with Trk receptor tyrosine kinases and regulates neurite outgrowth in nnr5-TrkA cells. J Biol Chem 2005;280:19461-19471. (Pubitemid 41379466)
38. Lo JF, Hayashi M, Woo-Kim S, Tian B, Huang JF, Fearns C, et al. Tid1, a cochaperone of the heat shock 70 protein and the mammalian counterpart of the Drosophila tumor suppressor l(2)tid, is critical for early embryonic development and cell survival. Mol Cell Biol 2004;24:2226-2236. (Pubitemid 38325979)